Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis.
about
Ginkgo biloba for intermittent claudicationNaftidrofuryl for intermittent claudicationGinkgo biloba for intermittent claudicationNaftidrofuryl for intermittent claudicationNaftidrofuryl for intermittent claudicationPentoxifylline for vascular health: a brief review of the literatureExercise Modulates Oxidative Stress and Inflammation in Aging and Cardiovascular DiseasesEmerging drugs in peripheral arterial diseaseEffect of intermittent pneumatic compression of foot and calf on walking distance, hemodynamics, and quality of life in patients with arterial claudication: a prospective randomized controlled study with 1-year follow-upPharmacological interventions for peripheral artery diseaseProgenitor cell release plus exercise to improve functional performance in peripheral artery disease: the PROPEL Study.Peripheral arterial disease.Cilostazol: treatment of intermittent claudication.Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient dataCurrent approach to the diagnosis and treatment of femoral-popliteal arterial disease. A systematic reviewPeripheral artery disease: current insight into the disease and its diagnosis and management.Effects of peripheral arterial disease on outcomes in advanced chronic systolic heart failure: a propensity-matched studySix-minute walk is a better outcome measure than treadmill walking tests in therapeutic trials of patients with peripheral artery disease.Complementary and alternative medicine in cardiovascular disease: what is the evidence it works?Systematic reviews and meta-analyses for more profitable strategies in peripheral artery diseasePeripheral arterial disease: epidemiology and drug therapy.Evidence-based symptom relief of intermittent claudication: efficacy and safety of cilostazol.Endovascular treatment of internal iliac artery stenosis in patients with buttock claudication.Clinical manifestation of atherosclerotic peripheral arterial disease and the role of cilostazol in treatment of intermittent claudication.Home-based walking exercise in peripheral artery disease: 12-month follow-up of the GOALS randomized trial.Pharmacologic treatment for intermittent claudication.Pathogenesis and management of alcoholic hepatitis.Antithrombotic therapy in peripheral artery disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Leg ulcers and pain: a review.Systemic antiatherosclerotic treatment for the peripheral arterial occlusive disease patient.Process of care and outcomes in patients with peripheral arterial diseaseComparative effectiveness study of self-directed walking exercise, lower extremity revascularization, and functional decline in peripheral artery diseaseManagement of peripheral arterial disease in the elderly: focus on cilostazolFunctional impairment in peripheral artery disease and how to improve it in 2013.Medical management and cardiovascular risk reduction in peripheral arterial diseasePeripheral artery disease: therapeutic advances.Exercise training and peripheral arterial disease.Peripheral arterial disease: Epidemiology, natural history, diagnosis and treatment.Pharmacologic therapy for intermittent claudication.Treatment strategies for peripheral artery disease.
P2860
Q24202149-C877343E-77D3-4D9F-9FF6-795FC7488C17Q24202499-39101CC1-591E-4BCA-8718-59EF9D69A6D1Q24241126-77241DCE-9FEE-4828-B1A1-0062FE8075A9Q24242960-EC11DDE2-AE6C-4535-9D12-EB7A7D526926Q24245391-1D1F552F-06E9-4693-955E-A228F9A9E345Q26766371-315D6B37-D3BB-4A99-873F-94117F7ED9C5Q26773005-33E43871-FB30-4792-ABE0-861AD9E54D66Q28195408-B4D81C4D-D7BC-4268-81BD-0D15128A88BEQ28218076-C300BAAE-D3CB-4539-BB8A-774B1098E0A8Q28218976-7A95C7D6-8EAB-4EBF-B226-8A92F6D802F8Q30409726-82B6B5B5-F493-4531-A1F7-265C05550E5CQ30863696-4DF48DD5-212B-46BE-94C9-3B73B0F90F65Q31989672-213CAF8C-51A2-4ECB-B06D-DA1BF99E4D52Q33416679-35EF1CB0-C519-406F-A278-EEB3718F8E61Q33743880-AC4BB78C-654A-421B-B9DD-5F1F8C5ED5F4Q33951581-4F0A5130-109B-4395-9524-3F285DC44E51Q34019065-427D1C9E-9C0A-4CCE-AA38-DA581797879FQ34131604-EC757727-9315-4EAF-BD26-EA6878455BB4Q34191329-2C295DDD-AF03-461F-8765-799A5418B61BQ34576281-CEDA0934-D1EC-4071-AF1B-11566A515685Q34714773-8D601F35-9E41-4ED4-9E20-6D7B0CADF940Q34785787-55CC2543-EB3A-45B0-989E-FF2844A9969CQ34951990-CFB97063-3CF4-451C-9B45-C962325044B3Q35015642-879CA7FE-CD91-420C-A50D-67AE2CFD96CDQ35021788-00F4EFF2-F79D-46E9-B21E-688576CDED49Q35113274-AE85CAB5-19FA-4482-86EA-07D96EDD0379Q35607638-ADCE4AB6-996A-47FF-BBFB-4FF5779B92A8Q35752591-414FC976-328E-45D0-AC7D-770A67BE26DFQ36113676-C848AD2C-11A0-47EB-AF8B-1E6BF2955C39Q36283702-CDB8229D-E165-4001-9FCA-994F758CD673Q36416691-59B78360-5C46-42E9-AB75-742CB339A517Q36728182-1C7DC73D-0BAA-4780-8777-81E8701890F2Q36892864-93CEB1A8-0857-4224-9324-330474899FC7Q36931733-CCC23502-F3BF-4D75-AB7E-0B1A42792E41Q36981330-CC5F0DA1-A8FE-4E19-962F-F77E7E896EA5Q37134500-67866940-7FCD-41AB-AF6B-EFEFDC14CDA2Q37157213-93B7F73F-AAA4-43E2-A36E-EC1694F6B15BQ37321632-20A23AB7-4E11-43F6-904A-29118BDC7E98Q37461418-88D25539-95EA-4348-917E-AA9FA55EDE67Q37519704-31C01657-A0B0-41D2-85A5-29D47224AECC
P2860
Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Treatment of intermittent clau ...... or nafronyl: a meta-analysis.
@ast
Treatment of intermittent clau ...... or nafronyl: a meta-analysis.
@en
Treatment of intermittent clau ...... or nafronyl: a meta-analysis.
@nl
type
label
Treatment of intermittent clau ...... or nafronyl: a meta-analysis.
@ast
Treatment of intermittent clau ...... or nafronyl: a meta-analysis.
@en
Treatment of intermittent clau ...... or nafronyl: a meta-analysis.
@nl
prefLabel
Treatment of intermittent clau ...... or nafronyl: a meta-analysis.
@ast
Treatment of intermittent clau ...... or nafronyl: a meta-analysis.
@en
Treatment of intermittent clau ...... or nafronyl: a meta-analysis.
@nl
P2093
P1476
Treatment of intermittent clau ...... or nafronyl: a meta-analysis.
@en
P2093
Bernardi E
Girolami A
Girolami B
Hettiarachchi R
Prandoni P
Ten Cate JW
P304
P356
10.1001/ARCHINTE.159.4.337
P407
P577
1999-02-01T00:00:00Z